RhumbLine Advisers’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-681
| Closed | -$37K | – | 3093 |
|
|
2022
Q1 | $37K | Buy |
681
+155
| +29% | +$8.42K | ﹤0.01% | 2986 |
|
|
2021
Q4 | $156K | Sell |
526
-18
| -3% | -$5.34K | ﹤0.01% | 2883 |
|
|
2021
Q3 | $211K | Buy |
544
+42
| +8% | +$16.3K | ﹤0.01% | 2896 |
|
|
2021
Q2 | $256K | Buy |
+502
| New | +$256K | ﹤0.01% | 2850 |
|